|
|
|
Volumn 116, Issue 1, 2000, Pages 15-18
|
|
Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease;Opredelenie terapevticheskoi éffektivnosti novogo otechestvennogo preparata "Semaks" pri zabolevaniiakh zritel'nogo nerva.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTH (4 7), PRO GLY PRO;
ACTH (4-7), PRO-GLY-PRO-;
CORTICOTROPIN;
DRUG DERIVATIVE;
NEUROPROTECTIVE AGENT;
PEPTIDE FRAGMENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COLOR VISION;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SCREENING;
ELECTROPHORESIS;
FEMALE;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
OPTIC NERVE DISEASE;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
VISUAL ACUITY;
VISUAL FIELD;
ADMINISTRATION, INTRANASAL;
ADOLESCENT;
ADRENOCORTICOTROPIC HORMONE;
ADULT;
AGED;
AGED, 80 AND OVER;
COLOR PERCEPTION;
DRUG EVALUATION;
ELECTROPHORESIS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROPROTECTIVE AGENTS;
OPTIC NERVE DISEASES;
PEPTIDE FRAGMENTS;
TREATMENT OUTCOME;
VISUAL ACUITY;
VISUAL FIELDS;
|
|
EID: 18844467370
PISSN: 0042465X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
